Page 3 - Phasei Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Phasei program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Phasei Program Today - Breaking & Trending Today

Dr Richardson on the Efficacy of Selinexor in TP53 Wild-Type Endometrial Cancer

Debra L. Richardson, MD, FACS, FACOG, discusses the impact of selinexor’s mechanism of action on the agent’s clinical efficacy in patients with TP53 wild-type advanced or recurrent endometrial cancer. ....

United States , University Of Oklahoma , Debral Richardson , University Of Oklahoma Ou College Medicine , Stephenson Cancer Center , Phasei Program , Ou Health , Gynecologic Oncology , Global Meeting , Endometrial Cancer ,

Moore Details Ongoing Research Aiming to Fill Unmet Needs in Ovarian Cancer

Kathleen N. Moore, MD, MS, expands on the importance of continuing to investigate PARP inhibitors in ovarian cancer and highlights key updates to have come out of the 2023 ESMO Congress ....

United States , University Of Oklahoma , Oklahoma City , Dana Farber Cancer Institute , Joycef Liu , Kathleenn Moore , Floortjej Backes , Shannonn Westin , University Of Oklahoma Health Stephenson Cancer Center , University Of Texas Md Anderson Cancer Center , Ohio State University Comprehensive Cancer Center , European Medicines Agency , Phasei Program , Stephenson Cancer Center , Clinical Research , University Of Oklahoma College Medicine , Science Summit , Gynecologic Oncology , Oklahoma College , Christina Washington , Oklahoma Health Stephenson Cancer Center , James Cancer Hospital , Cancer Center , Ovarian Cancer ,

Dr Vaishampayan on the Rationale For the SWOG-1931/PROBE Trial in Advanced RCC

Ulka Nitin Vaishampayan, MBBS, discusses the rationale for conducting the phase 3 SWOG 1931 trial in patients with advanced renal cell carcinoma.
....

United States , Ulka Nitin Vaishampayan , University Of Michigan , Phasei Program At Rogel Cancer Center , International Kidney Cancer Symposium , Phasei Program , Rogel Cancer Center , Kidney Cancer Symposium , Onclive Tv , Genitourinary Cancer , Renal Cell Carcinoma ,

Immune-Targeted Therapy Continues to Fall Short in Ovarian Cancer

Kathleen N. Moore, MD, MS, discusses the challenges with utilizing immune-targeted therapy for ovarian cancer, expands on the impact of the tumor microenvironment on the effectiveness of immune checkpoint inhibitors, and details ongoing research with different treatment approaches in ovarian cancer. ....

United States , University Of Oklahoma , Oklahoma City , Kathleenn Moore , Clinical Research , University Of Oklahoma College Medicine , Phasei Program , Stephenson Cancer Center , Science Summit , Gynecologic Oncology , Oklahoma College ,

Dr Moore on Continued Efforts to Utilize Immunotherapy in Ovarian Cancer

Kathleen N. Moore, MD, MS, discusses continued efforts to target the immune system in ovarian cancer through the use of immunotherapy, as well as alternative strategies being explored in this tumor type. ....

University Of Oklahoma , United States , Kathleenn Moore , University Of Oklahoma College Medicine , Phasei Program , Stephenson Cancer Center , Clinical Research , Gynecologic Oncology , Oklahoma College , Ovarian Cancer , Onclive Tv ,